Interbalkan European Medical Center
| ギリシャ | トルコ | オーストリア | |
| 開頭術 | - | から $5,650 | から $20,000 |
| 定位放射線手術 | - | から $4,500 | から $17,000 |
| 大腸癌に対する放射線療法 | - | から $7,000 | から $12,000 |
| 乳癌化学療法 | - | から $1,200 | から $15,000 |
Bookimedは髄芽腫治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。髄芽腫治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。髄芽腫治療の旅路でお一人になることはありません。
Greece treats medulloblastoma at specialized pediatric oncology units and university neurosurgery centers. Facilities in Athens and Thessaloniki provide comprehensive care. This includes tumor resection, chemotherapy, and radiation therapy. High-volume centers often maintain international academic partnerships for advanced protocols.
Bookimed Expert Insight: Interbalkan European Medical Center distinguishes itself through multiple global quality certifications. It holds Global Healthcare Accreditation and Temos International Healthcare Accreditation. These benchmarks prioritize the safety of international patients. The facility offers 36 specialized departments to manage long-term recovery needs.
Patient Consensus: Families often emphasize finding centers with dedicated neuro-oncology boards for embryonal tumors. Many note the importance of coordinating craniospinal irradiation early as surgery and radiation may occur in different facilities.
Greek medulloblastoma care is managed by a specialized Neuro-Oncology Multidisciplinary Team. These experts coordinate through Multidisciplinary Team Meetings. They integrate surgery, radiation, and chemotherapy into one strategy. Pediatric cases often involve networks like the Hellenic Neuro-Oncology Group for protocol-driven care.
Bookimed Expert Insight: Interbalkan European Medical Center in Thessaloniki leverages partnerships with Massachusetts General Hospital. This allows Greek multidisciplinary teams to access specialized global protocols. Such academic links are vital for medulloblastoma. They ensure complex pathology reviews meet top international standards.
Patient Consensus: Patients emphasize that the tumor board's expertise matters more than hospital branding. They note that pathology reviews and molecular subtype testing are critical for setting the correct roadmap.
The standard clinical protocol in Greece for medulloblastoma follows European Society for Paediatric Oncology (SIOP Europe) guidelines. This multi-modal approach includes maximal safe surgical resection. Treatment is risk-stratified based on age, metastatic status, and molecular biomarkers like WNT or SHH mutations.
Bookimed Expert Insight: Greek oncology centers like Interbalkan European Medical Center often collaborate with major US institutions like Harvard University. This connection ensures patients access molecular testing required for modern SIOP-HR-MB protocols. Our data shows these affiliations help bridge the gap between regional care and international research standards for high-risk cases.
Patient Consensus: Patients emphasize that the sequence of surgery, radiation, and chemotherapy is physically demanding. They note that having a coordinated team of neurologists, endocrinologists, and rehab specialists is vital for managing long-term side effects.
Greece does not currently have active proton beam therapy centers for medulloblastoma treatment. Patients requiring this advanced craniospinal irradiation must travel to European facilities in Germany, Italy, or France. Local oncology teams often coordinate these international transfers for complex pediatric cases.
Bookimed Expert Insight: Greece maintains high neurological standards through institutions like Interbalkan European Medical Center. This facility formally cooperates with Massachusetts General Hospital and Harvard University. Such academic ties help Greek neurosurgeons align local tumor resections with international proton protocols. This ensures patients are medically prepared before transferring to specialized centers abroad.
Patient Consensus: Patients note that traveling for pediatric brain tumor treatment requires significant logistical planning. Many emphasize verifying if a foreign center has specific experience with craniospinal irradiation.
Specialized Greek oncology units report a 66% 5-year survival rate for medulloblastoma. These outcomes align with specialized centers in the United States and Western Europe. However, nationwide registries show lower averages. Access to urban multidisciplinary pediatric care remains the primary survival driver.
Bookimed Expert Insight: Quality often depends on institutional partnerships rather than just location. For example, Interbalkan European Medical Center in Thessaloniki cooperates with Harvard University. This collaboration brings elite medical protocols to local pediatric neurosurgery cases.
Patient Consensus: Success depends on receiving treatment in specialized pediatric pathways rather than general hospitals. Families note that molecular subgrouping and quick transitions to radiation are the most critical factors.